Successful IOL implantation depends on PCO prevention

Article

Successful IOL implantation in paediatric eyes depends on further advances in PCO prevention

Results of a recent study examining adult autopsy globes show that implants fabricated from hydrophobic acrylic material (AcrySof, Alcon Laboratories) are associated with a much higher rate of posterior capsule opacification (PCO) than previously thought. It had been believed that this IOL was associated with low PCO rates and, therefore, it was being implanted in up to 96% of paediatric cataract surgery cases.

"We now know that the PCO rate is [about] 35%, no different from many other lenses," said Brian E. Zaugg, a medical student at the University of Utah, Salt Lake City, USA, and research fellow with the David J. Apple, MD, Laboratory for Ophthalmic Devices Research, Sullivan's Island, South Carolina, USA. "This puts into question the arbitrary use of only one IOL design in children.

"Our study shows that the postoperative time is actually the major factor associated with PCO development," Zaugg added. "Also considering that, when compared with adult eyes undergoing cataract surgery, paediatric eyes exhibit more rapid lens epithelial cell (LEC) proliferation and the IOL remains in the eye for a much longer duration, paediatric implants will have a much lesser chance to ward off PCO.

Study data

This study, which was conducted with Dr Apple, included 500 cadaver eyes that were post-extracapsular cataract extraction and lens implantation obtained between 2004 and 2007. The focus was on AcrySof IOLs, because according to a 2007 survey conducted by Wilson et al., they represent more than 96% of implants used in paediatric cataract surgery.

The data this far were obtained on the three-piece AcrySof IOLs because the single-piece lens model has only recently become available for accession in the laboratory's autopsy database, Zaugg noted. However the biomaterial used to fabricate the lens has remained unchanged.

"In summary, we have come a long way toward achieving our goal of safe and effective paediatric surgery," Zaugg concluded. "But in both adults and children we do need to attack the root of the problem by finding better means of removing lens material from the capsular bag, for example, using pharmacologic strategies."

Brian E. Zaugg is a medical student at the University of Utah, Salt Lake City, USA and a research fellow with the David J. Apple, MD, Laboratory for Ophthalmic Devices Research, Sullivan's Island, South Carolina, USA. He can by contacted by E-mail: brzaugg@hotmail.com

Mr Zaugg does not hold a proprietary interest in the subject matter.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Related Content
© 2025 MJH Life Sciences

All rights reserved.